Quest PharmaTech Inc. announced earnings results for the first quarter ended April 30, 2021. For the first quarter, the company announced net loss was CAD 585,928 compared to net income of CAD 106.035 million a year ago. Basic loss per share from continuing operations was CAD 0.003 compared to basic earnings per share from continuing operations of CAD 0.632 a year ago. Diluted loss per share from continuing operations was CAD 0.003 compared to diluted earnings per share from continuing operations of CAD 0.627 a year ago.